Publications

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.

Pirmani A , De Brouwer E , Arany Á , Oldenhof M , Passemiers A , Faes A , Kalincik T , Ozakbas S , Gouider R , Willekens B , Horakova D , Havrdova EK , Patti F , Prat A , Lugaresi A , Tomassini V , Grammond P , Cartechini E , Roos I , Boz C , Alroughani R , Amato MP , Buzzard K , Lechner-Scott J , Guimarães J , Solaro C , Gerlach O , Soysal A , Kuhle J , Sanchez-Menoyo JL , Spitaleri D , Csepany T , Van Wijmeersch B , Ampapa R , Prevost J , Khoury SJ , Van Pesch V , John N , Maimone D , Weinstock-Guttman B , Laureys G , McCombe P , Blanco Y , Altintas A , Al-Asmi A , Garber J , Van der Walt A , Butzkueven H , de Gans K , Rozsa C , Taylor B , Al-Harbi T , Sas A , Rajda C , Gray O , Decoo D , Carroll WM , Kermode AG , Fabis-Pedrini M , Mason D , Perez-Sempere A , Simu M , Shuey N , Singhal B , Cauchi M , Hardy TA , Ramanathan S , Lalive P , Sirbu CA , Hughes S , Castillo Trivino T , Peeters LM , Moreau Y
NPJ digital medicine - Jul 2025

Anterior temporal lobectomy and selective AmygdaloHippocampectomy complications across Europe: review, meta-analysis, and Delphi consensus.

Karagianni MD , Schijns OEMG , Brotis A , Tasiou A , Auer C , Blauwblomme T , Budke M , Campos AR , Candela-Cantó S , Clusmann H , Consales A , Cossu M , Delev D , Dorfer C , Dorfmüller G , Egge A , Eröss L , Ferrand-Sorbets S , Giordano F , Isler C , Ivanovic J , Kalbhenn T , Karppinen A , Koroknay-Pal P , Krayenbühl N , von Lehe M , Marras CE , Mavridis I , Nilsson D , Onken J , Raftopoulos C , Rizzi M , van Roost D , Rössler K , Roth J , Rumia J , Seromenho-Santos A , Sauvigny T , Scavarda D , Scheiwe C , Schaller K , Schuind S , Strauss I , Theys T , Uzan M , Fountas KN ,
Brain & spine - 2025

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.

Ossenkoppele R , Coomans EM , Apostolova LG , Baker SL , Barthel H , Beach TG , Benzinger TLS , Betthauser T , Bischof GN , Bottlaender M , Bourgeat P , den Braber A , Brendel M , Brickman AM , Cash DM , Carrillo MC , Coath W , Christian BT , Dickerson BC , Dore V , Drzezga A , Feizpour A , van der Flier WM , Franzmeier N , Frisoni GB , Garibotto V , van de Giessen E , Domingo-Gispert J , Gnoerich J , Gu Y , Guan Y , Hanseeuw BJ , Harrison TM , Jack CR , Jaeger E , Jagust WJ , Jansen WJ , La Joie R , Johnson KA , Johnson SC , Kennedy IA , Kim JP , van Laere K , Lagarde J , Lao P , Luchsinger JA , Kern S , Kreisl WC , Malotaux V , Malpetti M , Manly JJ , Mao X , Mattsson-Carlgren N , , Messerschmidt K , Minguillon C , Mormino EM , O'Brien JT , Palmqvist S , Peretti DE , Petersen RC , Pijnenburg YAL , Pontecorvo MJ , Poirier J , , Rabinovici GD , Rahmouni N , Risacher SL , Rosa-Neto P , Rosen H , Rowe CC , Rowe JB , Rullmann M , Salman Y , Sarazin M , Saykin AJ , Schneider JA , Schöll M , Schott JM , Seo SW , Serrano GE , Shcherbinin S , Shekari M , Skoog I , Smith R , Sperling RA , Spruyt L , Stomrud E , Strandberg O , Therriault J , Xie F , Vandenberghe R , Villemagne VL , Villeneuve S , Visser PJ , Vossler H , Young CB , Groot C , Hansson O
Nature neuroscience - Jul 2025

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Jessen F , Arbizu J , Boada M , Balasa M , Bennys K , Boban M , Bürger K , Chincarini A , Cagnin A , De Deyn PP , Düzel E , Engelborghs S , Ewers M , Exalto LG , van der Flier WM , Fortea J , Frederiksen KS , Frisoni GB , Frölich L , Garza-Martinez AJ , Grimmer T , Hanseeuw B , Hort J , Ivanoiu A , Kehoe PG , Kennelly SP , Kern S , Klöppel S , Krajčovičová L , Kramberger MG , McGuinness B , Mecocci P , Oberstein TJ , Ousset PJ , Paquet C , Perneczky R , Piazza F , Plantone D , Rainero I , Sacco G , Salmon E , Santana I , Scarmeas N , Schneider A , Schott JM , Solje E , Stefanova E , Stögmann E , Strauss M , Sutovsky S , Waldemar G , Winblad B
The journal of prevention of Alzheimer's disease - Jul 2025

Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.

Cagol A , Schaedelin S , Ocampo-Pineda M , Benkert P , Melie-Garcia L , Luchetti L , Yaldizli Ö , Oechtering J , D'Souza M , Fischer-Barnicol B , Müller S , Finkener S , Vehoff J , Disanto G , Chan A , Pot C , Zecca C , Derfuss T , Lieb JM , Diepers M , Wagner F , Du Pasquier R , Lalive PH , Pravatà E , Kim OC , Hoepner R , Roth P , Gobbi C , Leppert D , Battaglini M , Kappos L , Sormani MP , Kuhle J , Granziera C ,
Journal of neurology - Jul 2025

Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS.

van Maurik IS , Altomare D , Collij LE , Caprioglio C , Moro C , Garibotto V , Demonet JF , Scheltens P , Farrer G , Gismondi R , Stephens AW , Gispert JD , Molinuevo JL , Grau-Rivera O , Edison P , Walker Z , Jessen F , Dzrezga A , Zeyen P , Payoux P , Saint-Aubert L , Delrieu J , Nordberg A , Barkhof F , Frisoni GB , Berkhof J
European journal of neurology - Jun 2025